Invea Therapeutics, Inc S-1/A
S-1/A · Invea Therapeutics, Inc · Filed Jan 26, 2024
Documents
- S-1
S-1/A
- EX-23.1
EXHIBIT 23.1
- GRAPHIClg_inveatherapeutics-4c.jpg
GRAPHIC
- GRAPHICfc_pipelinee-4c.jpg
GRAPHIC
- GRAPHICtbl_majortheraoeutic-4c.jpg
GRAPHIC
- GRAPHICfc_fig01invea-4c.jpg
GRAPHIC
- GRAPHICfc_imidsubmet-4c.jpg
GRAPHIC
- GRAPHICfc_fig03dysreg-4c.jpg
GRAPHIC
- GRAPHICfc_fig04cellbio-4c.jpg
GRAPHIC
- GRAPHICfc_fig05inflama-4c.jpg
GRAPHIC
- GRAPHICfc_fig06mediator-4c.jpg
GRAPHIC
- GRAPHICtb_adseverity-4c.jpg
GRAPHIC
- GRAPHICtb_placebo-4c.jpg
GRAPHIC
- GRAPHIClc_fig08primary-bw.jpg
GRAPHIC
- GRAPHIClc_fig09igascor01-bw.jpg
GRAPHIC
- GRAPHIClc_fig09igascor02-bw.jpg
GRAPHIC
- GRAPHICtb_enzyme-4c.jpg
GRAPHIC
- GRAPHICtb_report-4c.jpg
GRAPHIC
- GRAPHIClc_fig12plasma-bw.jpg
GRAPHIC
- GRAPHICtb_system-4c.jpg
GRAPHIC
- GRAPHIClc_fig14inva8001-bw.jpg
GRAPHIC
- GRAPHICtb_system01-4c.jpg
GRAPHIC
- GRAPHICtb_assesment-4c.jpg
GRAPHIC
- GRAPHICtb_system02-4c.jpg
GRAPHIC
- GRAPHICph_intactskin-4c.jpg
GRAPHIC
- GRAPHICtb_mean-bw.jpg
GRAPHIC
- GRAPHICfc_lpsatpmousemodel-4c.jpg
GRAPHIC
- GRAPHICbc_plasma-4c.jpg
GRAPHIC